BAKER BROS ADVISORS LLC Insider Trading for February 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for BAKER BROS ADVISORS LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of BAKER BROS ADVISORS LLC for February 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.20 | 493 | 37,565 | 9,060,972 | 9.1 M to 9.1 M (-0.01 %) |
| Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.20 | 76 | 5,791 | 1,432,586 | 1.4 M to 1.4 M (-0.01 %) |
| Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.20 | 13 | 991 | 279,226 | 279.2 K to 279.2 K (0.00 %) |
| Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.20 | 8 | 610 | 179,043 | 179.1 K to 179 K (0.00 %) |
| Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.20 | 1 | 76 | 51,256 | 51.3 K to 51.3 K (0.00 %) |
| Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.20 | 9 | 686 | 195,161 | 195.2 K to 195.2 K (0.00 %) |
| Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 17.59 | 8,250 | 145,118 | 0 | |
| Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 17.59 | 8,250 | 145,118 | 0 | |
| Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.20 | 742 | 56,540 | 9,061,465 | 9.1 M to 9.1 M (-0.01 %) |
| Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.20 | 114 | 8,687 | 1,432,662 | 1.4 M to 1.4 M (-0.01 %) |
| Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.20 | 20 | 1,524 | 279,239 | 279.3 K to 279.2 K (-0.01 %) |
| Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.20 | 11 | 838 | 179,051 | 179.1 K to 179.1 K (-0.01 %) |
| Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.20 | 1 | 76 | 51,257 | 51.3 K to 51.3 K (0.00 %) |
| Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.20 | 13 | 991 | 195,170 | 195.2 K to 195.2 K (-0.01 %) |
| Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.66 | 31,482 | 2,413,501 | 9,062,207 | 9.1 M to 9.1 M (-0.35 %) |
| Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.66 | 4,833 | 370,512 | 1,432,776 | 1.4 M to 1.4 M (-0.34 %) |
| Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.66 | 833 | 63,860 | 279,259 | 280.1 K to 279.3 K (-0.30 %) |
| Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.66 | 484 | 37,105 | 179,062 | 179.5 K to 179.1 K (-0.27 %) |
| Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.66 | 37 | 2,837 | 51,258 | 51.3 K to 51.3 K (-0.07 %) |
| Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.66 | 539 | 41,321 | 195,183 | 195.7 K to 195.2 K (-0.28 %) |
| Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 77.81 | 620 | 48,239 | 9,093,689 | 9.1 M to 9.1 M (-0.01 %) |
| Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 77.81 | 95 | 7,392 | 1,437,609 | 1.4 M to 1.4 M (-0.01 %) |
| Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 77.81 | 16 | 1,245 | 280,092 | 280.1 K to 280.1 K (-0.01 %) |
| Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 77.81 | 10 | 778 | 179,546 | 179.6 K to 179.5 K (-0.01 %) |
| Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 77.81 | 1 | 78 | 51,295 | 51.3 K to 51.3 K (0.00 %) |
| Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 77.81 | 11 | 856 | 195,722 | 195.7 K to 195.7 K (-0.01 %) |
| Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 78.13 | 6,506 | 508,342 | 9,094,309 | 9.1 M to 9.1 M (-0.07 %) |
| Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 78.13 | 999 | 78,056 | 1,437,704 | 1.4 M to 1.4 M (-0.07 %) |
| Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 78.13 | 172 | 13,439 | 280,108 | 280.3 K to 280.1 K (-0.06 %) |
| Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 78.13 | 100 | 7,813 | 179,556 | 179.7 K to 179.6 K (-0.06 %) |
| Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 78.13 | 8 | 625 | 51,296 | 51.3 K to 51.3 K (-0.02 %) |
| Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 78.13 | 112 | 8,751 | 195,733 | 195.8 K to 195.7 K (-0.06 %) |
| Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Buy | M | 17.59 | 8,250 | 145,118 | 9,100,815 | 9.1 M to 9.1 M (+0.09 %) |
| Feb 28 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Buy | M | 17.59 | 8,250 | 145,118 | 1,438,703 | 1.4 M to 1.4 M (+0.58 %) |
| Feb 27 2019 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 2.80 | 20,000 | 56,000 | 0 | |
| Feb 27 2019 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 2.80 | 20,000 | 56,000 | 0 | |
| Feb 27 2019 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Buy | M | 2.80 | 20,000 | 56,000 | 29,288,793 | 29.3 M to 29.3 M (+0.07 %) |
| Feb 27 2019 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Buy | M | 2.80 | 20,000 | 56,000 | 4,428,264 | 4.4 M to 4.4 M (+0.45 %) |
| Feb 06 2019 | KNSA | Kiniksa Pharmaceut ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | A | 0.00 | 1,818,475 | 0 | 8,837,349 | |
| Feb 06 2019 | KNSA | Kiniksa Pharmaceut ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | A | 0.00 | 181,525 | 0 | 916,043 |